← back to search

Edythe D. London

University of California, Los Angeles · US
Area of research
Cellular and Molecular Neuroscience · Cognitive Neuroscience
Research interest
Research interests include Neurotransmitter Receptor Influence on Behavior, Nicotinic Acetylcholine Receptors Study, Neuroscience and Neuropharmacology Research, and Neural and Behavioral Psychology Studies.
h-index
92
citations
34,326
works
526
NIH funding
primary concept
email

Recent publications

Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial
Neuropsychopharmacology 2025cited by 7position: middledoi
Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity
JAMA Psychiatry 2024cited by 36position: middledoi
A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus
Nature Protocols 2022cited by 91position: middledoi
Mapping cortical and subcortical asymmetries in substance dependence: Findings from the ENIGMA Addiction Working Group
Addiction Biology 2021cited by 41position: middledoi
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics
Neuropsychopharmacology 2021cited by 25position: middledoi
Human Brain Imaging Links Dopaminergic Systems to Impulsivity
Current topics in behavioral neurosciences 2020cited by 23position: firstdoi
Diminished cortical response to risk and loss during risky decision making in alcohol use disorder
Drug and Alcohol Dependence 2020cited by 20position: lastdoi
Identifying Nootropic Drug Targets via Large-Scale Cognitive GWAS and Transcriptomics
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 7position: middledoi
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
The American Journal of Drug and Alcohol Abuse 2019cited by 142position: lastdoi
Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study
Addiction Biology 2019cited by 85position: middledoi
Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders
Neuroscience & Biobehavioral Reviews 2019cited by 60position: middledoi
Neural basis of smoking‐induced relief of craving and negative affect: Contribution of nicotine
Addiction Biology 2018cited by 30position: lastdoi
Stages of dysfunctional decision-making in addiction
Pharmacology Biochemistry and Behavior 2017cited by 191position: lastdoi
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Frontiers in Psychiatry 2017cited by 190position: lastdoi
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study
Neuropsychopharmacology 2017cited by 64position: middledoi
Brain activation during emotion regulation in women with premenstrual dysphoric disorder
Psychological Medicine 2017cited by 59position: lastdoi
Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers
Psychopharmacology 2017cited by 58position: lastdoi
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users
Neuropsychopharmacology 2017cited by 28position: lastdoi
A phenome-wide examination of neural and cognitive function
Scientific Data 2016cited by 440position: middledoi
Emotion regulation in women with premenstrual dysphoric disorder
Archives of Women s Mental Health 2016cited by 81position: middledoi
Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users
Molecular Psychiatry 2016cited by 63position: lastdoi
Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment
Neuropsychopharmacology 2015cited by 132position: lastdoi
Striatal D<sub>1</sub>- and D<sub>2</sub>-type Dopamine Receptors Are Linked to Motor Response Inhibition in Human Subjects
Journal of Neuroscience 2015cited by 88position: lastdoi
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study
Neuropsychopharmacology 2015cited by 78position: middledoi
Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study
Molecular Psychiatry 2015cited by 65position: middledoi
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence
The International Journal of Neuropsychopharmacology 2015cited by 62position: lastdoi
Genetic imaging consortium for addiction medicine
Progress in brain research 2015cited by 25position: middledoi
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
Brain Research 2014cited by 181position: firstdoi
Risky Decision Making, Prefrontal Cortex, and Mesocorticolimbic Functional Connectivity in Methamphetamine Dependence
JAMA Psychiatry 2014cited by 174position: lastdoi
Predicting risky choices from brain activity patterns
Proceedings of the National Academy of Sciences 2014cited by 163position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dara G. Ghahremani · University of California, Los Angeles12 papers (2012–2020)M. Mandelkern · University of California, Irvine9 papers (2012–2017)Angelica M. Morales · Oregon Health & Science University7 papers (2012–2016)Milky Kohno · Oregon Health & Science University6 papers (2013–2020)Gerhard Hellemann · Alabama Department of Public Health6 papers (2012–2018)Chelsea L. Robertson · Community College of Baltimore County5 papers (2012–2017)Fred W. Sabb · Oregon Research Institute5 papers (2014–2016)Robert M. Bilder · Neurobehavioral Systems5 papers (2014–2016)Kenji Ishibashi · Tokyo Metropolitan Institute of Gerontology4 papers (2013–2015)Nicole Petersen · University of California, Los Angeles4 papers (2016–2025)Tyrone D. Cannon · Connecticut Mental Health Center4 papers (2014–2016)Michael E. Ballard · Utah Valley University3 papers (2014–2017)Kyoji Okita · National Institute of Mental Health3 papers (2016–2017)Eliza Congdon · University of California, Los Angeles3 papers (2014–2016)Stephanie M. Groman · Yale University3 papers (2012–2014)Amira K. Brown · Charles R. Drew University of Medicine and Science3 papers (2012–2015)Steven M. Berman · University of California, Los Angeles3 papers (2012–2017)Katherine H. Karlsgodt · University of California, Los Angeles3 papers (2014–2016)Andrea J. Rapkin · University of California, Los Angeles3 papers (2012–2017)Buyean Lee · University of California, Los Angeles3 papers (2012–2012)